Wall Street fluctuated as the country held riveted by former FBI director James Comey's public Senate testimony. When asked, Comey said he had "no doubt" that Russian government officials had attempted to interfere in the 2016 election. Valeant Pharmaceuticals (VRX) rose after agreeing to sell iNova Pharmaceuticals for $930 million in an all-cash deal. The deal is expected to close in the second half of the year. J.M. Smucker (SJM) was lower even after topping quarterly earnings estimates. Sales declined 1%, though did manage to come in higher than analysts' target. Nordstrom (JWN) led the S&P 500 after announcing that the retailer was exploring the possibility of a "going private transaction." The company's board has formed a special committee to weigh the option.
More from Video
How quickly do we find support, is what we'll want to know now, as the correction is occurring while economic optimism builds.
Despite the president's promise of no stimulus until after Nov. 3, there are no signs yet that this is the sort of correlated selling that leads to a deep correction.
Salesforce, Amgen and Honeywell will give a lift to the DJIA going forward.
CAG has hung onto the bulk of its recent gains, and could rise to the $50 area, according to the charts and indicators.